Monti P - Search Results

1

Characterization of the p53 mutants ability to inhibit p73 beta transactivation using a yeast-based functional assay.

Monti P, Campomenosi P, Ciribilli Y, Iannone R, Aprile A, Inga A, Tada M, Menichini P, Abbondandolo A, Fronza G. Monti P, et al. Oncogene. 2003 Aug 14;22(34):5252-60. doi: 10.1038/sj.onc.1206511. Oncogene. 2003. PMID: 12917626

2

p53 is frequently mutated in Barrett's metaplasia of the intestinal type.

Campomenosi P, Conio M, Bogliolo M, Urbini S, Assereto P, Aprile A, Monti P, Aste H, Lapertosa G, Inga A, Abbondandolo A, Fronza G. Campomenosi P, et al. Among authors: monti p. Cancer Epidemiol Biomarkers Prev. 1996 Jul;5(7):559-65. Cancer Epidemiol Biomarkers Prev. 1996. PMID: 8827361

3

Determining mutational fingerprints at the human p53 locus with a yeast functional assay: a new tool for molecular epidemiology.

Inga A, Iannone R, Monti P, Molina F, Bolognesi M, Abbondandolo A, Iggo R, Fronza G. Inga A, et al. Among authors: monti p. Oncogene. 1997 Mar 20;14(11):1307-13. doi: 10.1038/sj.onc.1200952. Oncogene. 1997. PMID: 9178891

4

Simple identification of dominant p53 mutants by a yeast functional assay.

Inga A, Cresta S, Monti P, Aprile A, Scott G, Abbondandolo A, Iggo R, Fronza G. Inga A, et al. Among authors: monti p. Carcinogenesis. 1997 Oct;18(10):2019-21. doi: 10.1093/carcin/18.10.2019. Carcinogenesis. 1997. PMID: 9364015

5

Heterogeneous p53 mutations in a Burkitt lymphoma from an AIDS patient with monoclonal c-myc and VDJ rearrangements.

Campomenosi P, Fronza G, Ottaggio L, Roncella S, Inga A, Bogliolo M, Monti P, Assereto P, Moro F, Cutrona G, Bozzo S, Chiorazzi N, Abbondandolo A, Ferrarini M. Campomenosi P, et al. Among authors: monti p. Int J Cancer. 1997 Dec 10;73(6):816-21. doi: 10.1002/(sici)1097-0215(19971210)73:6<816::aid-ijc8>3.0.co;2-5. Int J Cancer. 1997. PMID: 9399658

6

Ultraviolet-light induced p53 mutational spectrum in yeast is indistinguishable from p53 mutations in human skin cancer.

Inga A, Scott G, Monti P, Aprile A, Abbondandolo A, Burns PA, Fronza G. Inga A, et al. Among authors: monti p. Carcinogenesis. 1998 May;19(5):741-6. doi: 10.1093/carcin/19.5.741. Carcinogenesis. 1998. PMID: 9635858

7

N-(2-chloroethyl)-N-nitrosourea tethered to lexitropsin induces minor groove lesions at the p53 cDNA that are more cytotoxic than mutagenic.

Inga A, Chen FX, Monti P, Aprile A, Campomenosi P, Menichini P, Ottaggio L, Viaggi S, Abbondandolo A, Gold B, Fronza G. Inga A, et al. Among authors: monti p. Cancer Res. 1999 Feb 1;59(3):689-95. Cancer Res. 1999. PMID: 9973219

8

Relationship between DNA methylation and mutational patterns induced by a sequence selective minor groove methylating agent.

Kelly JD, Inga A, Chen FX, Dande P, Shah D, Monti P, Aprile A, Burns PA, Scott G, Abbondandolo A, Gold B, Fronza G. Kelly JD, et al. Among authors: monti p. J Biol Chem. 1999 Jun 25;274(26):18327-34. doi: 10.1074/jbc.274.26.18327. J Biol Chem. 1999. PMID: 10373436 Free article.

9

5-methylcytosine at HpaII sites in p53 is not hypermutable after UVC irradiation.

Monti P, Inga A, Scott G, Aprile A, Campomenosi P, Menichini P, Ottaggio L, Viaggi S, Abbondandolo A, Burns PA, Fronza G. Monti P, et al. Mutat Res. 1999 Dec 16;431(1):93-103. doi: 10.1016/s0027-5107(99)00187-6. Mutat Res. 1999. PMID: 10656489

10

p53 mutations experimentally induced by 8-methoxypsoralen plus UVA (PUVA) differ from those found in human skin cancers in PUVA-treated patients.

Monti P, Inga A, Aprile A, Campomenosi P, Menichini P, Ottaggio L, Viaggi S, Ghigliotti G, Abbondandolo A, Fronza G. Monti P, et al. Mutagenesis. 2000 Mar;15(2):127-32. doi: 10.1093/mutage/15.2.127. Mutagenesis. 2000. PMID: 10719037

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

496 results

Search Page

Filters